Published in Prev Med on January 01, 1991
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol (2008) 3.11
Data dredging, bias, or confounding. BMJ (2002) 2.87
Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A (1994) 2.70
Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ (1994) 2.54
Psychosocial factors and public health: a suitable case for treatment? J Epidemiol Community Health (2003) 2.53
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Utilisation of hormone replacement therapy by women doctors. BMJ (1995) 2.35
Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid. JAMA Intern Med (2014) 2.20
Identifying and avoiding bias in research. Plast Reconstr Surg (2010) 2.19
Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ (2016) 2.17
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause (2011) 2.06
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol (2007) 1.88
Risks and benefits of hormone replacement therapy: the evidence speaks. CMAJ (2003) 1.63
Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health (1995) 1.49
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
The need for randomised controlled trials in urogynaecology. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.40
In defense of the randomized controlled trial for health promotion research. Am J Public Health (2006) 1.38
Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res (2000) 1.38
Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci U S A (2001) 1.30
Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol (2010) 1.24
Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med (2009) 1.21
Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ (2004) 1.18
Women's use of hormone replacement therapy for disease prevention; results of a community survey. Br J Gen Pract (2002) 1.15
Asymptomatic hypertriglyceridaemia. BMJ (1992) 1.14
The impact of clinical trials on the use of hormone replacement therapy. A population-based study. J Gen Intern Med (2005) 1.14
Vascular cell signaling by membrane estrogen receptors. Steroids (2008) 1.11
Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health (2005) 1.11
Membrane-initiated actions of estrogen on the endothelium. Mol Cell Endocrinol (2009) 1.10
Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev (2005) 1.10
Ethnic differences in hormone replacement prescribing patterns. J Gen Intern Med (1999) 1.10
Socioeconomic position and hormone replacement therapy use: explaining the discrepancy in evidence from observational and randomized controlled trials. Am J Public Health (2004) 1.10
Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy. J Gen Intern Med (1999) 1.09
Hormone replacement therapy: characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records. J Epidemiol Community Health (1995) 1.07
The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Womens Health (2007) 1.07
Bioidentical hormone micronized progesterone. Can Fam Physician (2012) 1.06
A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis (1994) 1.05
Discontinuing hormone replacement therapy: attenuating the effect on CVD risk with lifestyle changes. Am J Prev Med (2007) 1.00
Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010. Obstet Gynecol (2014) 0.99
Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease. Mini Rev Med Chem (2012) 0.99
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol (1999) 0.99
Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle. Am J Physiol Heart Circ Physiol (2005) 0.98
Usefulness of Mendelian randomization in observational epidemiology. Int J Environ Res Public Health (2010) 0.97
A case-control study on the effect of hormone replacement therapy on ischaemic heart disease. Br J Gen Pract (2003) 0.93
Tracking progesterone receptor-mediated actions in breast cancer. Pharmacol Ther (2013) 0.91
All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts. World Rev Nutr Diet (2011) 0.90
Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol (1996) 0.89
Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations. Am J Public Health (2000) 0.89
Breast cancer risk associated with different HRT formulations: a register-based case-control study. BMC Womens Health (2006) 0.89
Comparing hormone therapy effects in two RCTs and two large observational studies that used similar methods for comprehensive data collection and outcome assessment. BMJ Open (2013) 0.89
Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation. PLoS One (2013) 0.88
Using Mendelian randomisation to infer causality in depression and anxiety research. Depress Anxiety (2013) 0.88
Intrawound vancomycin to prevent infections after spine surgery: a systematic review and meta-analysis. Eur Spine J (2014) 0.86
The menopause and its treatment in perspective. Postgrad Med J (2001) 0.86
Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? Heart (2000) 0.86
Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study. Osteoporos Int (2013) 0.86
Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83
Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes. Menopause (2011) 0.83
Endothelial function in women of the Kronos Early Estrogen Prevention Study. Climacteric (2015) 0.82
Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Semin Reprod Med (2014) 0.82
An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease. Stat Biosci (2013) 0.82
Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. Drugs (1994) 0.82
Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One (2013) 0.82
STROBE and STREGA: instruments for improving transparency and quality of reporting scientific results. Eur J Epidemiol (2008) 0.82
Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies. J Zhejiang Univ Sci B (2014) 0.81
Phytoestrogen genistein up-regulates endothelial nitric oxide synthase expression via activation of cAMP response element-binding protein in human aortic endothelial cells. Endocrinology (2012) 0.81
Rapid changes in cardiac myofilament function following the acute activation of estrogen receptor-alpha. PLoS One (2012) 0.80
Systemic effects of vaginally administered estrogen therapy: a review. Female Pelvic Med Reconstr Surg (2010) 0.80
Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women. Atherosclerosis (2008) 0.80
Hormones and heart disease: what we thought, what we have learned, what we still need to know. Trans Am Clin Climatol Assoc (2002) 0.80
Meta-analysis of the association of the rs2234693 and rs9340799 polymorphisms of estrogen receptor alpha gene with coronary heart disease risk in Chinese Han population. Int J Med Sci (2013) 0.80
Personalizing Behavioral Interventions Through Single-Patient (N-of-1) Trials. Soc Personal Psychol Compass (2014) 0.80
Effect of acute transdermal estrogen administration on basal, mental stress and cold pressor-induced sympathetic responses in postmenopausal women. Clin Auton Res (2005) 0.79
Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease. Curr Treat Options Cardiovasc Med (2003) 0.79
Coronary artery disease in women. Can Fam Physician (1998) 0.79
17β-estradiol increases expression of the oxidative stress response and DNA repair protein apurinic endonuclease (Ape1) in the cerebral cortex of female mice following hypoxia. J Steroid Biochem Mol Biol (2013) 0.79
Why do women doctors in the UK take hormone replacement therapy? J Epidemiol Community Health (1997) 0.79
Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update. Int J Womens Health (2010) 0.79
Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals. BMJ (1998) 0.79
Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A review. Drugs (1994) 0.79
Biosensor-based approach identifies four distinct calmodulin-binding domains in the G protein-coupled estrogen receptor 1. PLoS One (2014) 0.79
Effects of estrogen treatment on arterial wall structure and function. Drugs (1994) 0.79
Changes in elderly women's health-related quality of life following discontinuation of hormone replacement therapy. BMC Womens Health (2005) 0.79
Data analysis methods and the reliability of analytic epidemiologic research. Epidemiology (2008) 0.78
The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus. BMC Cardiovasc Disord (2008) 0.78
Mammographic changes in postmenopausal women on hormonal replacement therapy. Eur Radiol (1997) 0.78
Do patients with osteoarthritis get the clinical research they need? Ann Rheum Dis (2000) 0.78
Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk. Ann Surg (1998) 0.78
Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status. Metabolism (2010) 0.78
Health status of users of hormone replacement therapy by hysterectomy status in Western Australia. J Epidemiol Community Health (2003) 0.78
Post menopausal hormones and measures of subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. Prev Med (2007) 0.77
Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids. Br J Cancer (2004) 0.77
Critique of the International Agency for Research on Cancer's meta-analyses of the association of sunbed use with risk of cutaneous malignant melanoma. Dermatoendocrinol (2009) 0.76
Genistein activates endothelial nitric oxide synthase in broiler pulmonary arterial endothelial cells by an Akt-dependent mechanism. Exp Mol Med (2010) 0.76
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial. Ecancermedicalscience (2008) 0.76
A critical appraisal of epidemiological studies comes from basic knowledge: a reader's guide to assess potential for biases. World J Emerg Surg (2007) 0.76
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart (1998) 0.75
Age at menarche and risk of major cardiovascular diseases: Evidence of birth cohort effects from a prospective study of 300,000 Chinese women. Int J Cardiol (2016) 0.75
Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17
Body weight and mortality among women. N Engl J Med (1995) 11.04
Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98
Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84
Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59
Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64
Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43
Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87
A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol (1990) 7.24
Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09
Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med (2001) 7.07
Guidelines for healthy weight. N Engl J Med (1999) 7.03
Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02
Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92
Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37
Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med (2001) 6.23
Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21
Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17
A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12
A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06
Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst (2001) 5.97
Cost-effectiveness of screening for colorectal cancer in the general population. JAMA (2000) 5.88
Validation of a youth/adolescent food frequency questionnaire. Prev Med (1997) 5.78
Current estimates of the economic cost of obesity in the United States. Obes Res (1998) 5.52
Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst (2001) 5.33
Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993) 5.31
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09
Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05
Intake of trans fatty acids and risk of coronary heart disease among women. Lancet (1993) 5.00
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96
Television viewing as a cause of increasing obesity among children in the United States, 1986-1990. Arch Pediatr Adolesc Med (1996) 4.91
Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84
A random-effects regression model for meta-analysis. Stat Med (1995) 4.83
Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81
Risk of overweight among adolescents who were breastfed as infants. JAMA (2001) 4.80
Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78
Use of statistical analysis in the New England Journal of Medicine. N Engl J Med (1983) 4.76
Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74
Menopause and the risk of coronary heart disease in women. N Engl J Med (1987) 4.70
A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61
A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51
A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50
Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49
Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49
Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA (1999) 4.43
Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37
Smoking cessation and decreased risk of stroke in women. JAMA (1993) 4.36
Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30
Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr (2001) 4.26
Development and reproducibility of a food frequency questionnaire to assess diets of older children and adolescents. J Am Diet Assoc (1995) 4.25
Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22
A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 4.12
Physical activity and risk of stroke in women. JAMA (2000) 3.95
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91
Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst (1995) 3.88
A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med (1991) 3.85
Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med (1999) 3.82
Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol (1987) 3.77
Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76
Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol (1997) 3.75
Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med (1998) 3.73
Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly? Ann Intern Med (1992) 3.71
The validity of recalled weight among younger women. Int J Obes Relat Metab Disord (1995) 3.68
A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA (1991) 3.67
Family dinner and diet quality among older children and adolescents. Arch Fam Med (2000) 3.64
Body weight, weight change, and risk for hypertension in women. Ann Intern Med (1998) 3.56
A prospective study of nutritional factors and hypertension among US men. Circulation (1992) 3.51
Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst (1994) 3.45
A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst (1993) 3.40
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35
A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med (1988) 3.33
A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst (1994) 3.32
Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med (1995) 3.29
A prospective study of benign breast disease and the risk of breast cancer. JAMA (1992) 3.29
A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health (1996) 3.28
Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25
Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst (1995) 3.24
Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst (1999) 3.22
A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med (1985) 3.21
Prospective study of shift work and risk of coronary heart disease in women. Circulation (1995) 3.18
Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer (2009) 3.13
A prospective study of risk factors for pulmonary embolism in women. JAMA (1997) 3.12
Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst (1995) 3.10
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol (2001) 3.09
A prospective study of body mass index, weight change, and risk of stroke in women. JAMA (1997) 3.04